On Tuesday, Qiagen NV (NYSE: QGEN) was 0.38% up from the session before settling in for the closing price of $42.47. A 52-week range for QGEN has been $37.63 – $47.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 6.09%. When this article was written, the company’s average yearly earnings per share was at 2.05%. With a float of $214.41 million, this company’s outstanding shares have now reached $216.12 million.
Let’s determine the extent of company efficiency that accounts for 5765 employees. In terms of profitability, gross margin is 49.6%, operating margin of 5.11%, and the pretax margin is 6.12%.
Qiagen NV (QGEN) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Qiagen NV stocks. The insider ownership of Qiagen NV is 0.79%, while institutional ownership is 74.45%. The most recent insider transaction that took place on Sep 11 ’24, was worth 1,150,000.
Qiagen NV (QGEN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.05% per share during the next fiscal year.
Qiagen NV (NYSE: QGEN) Trading Performance Indicators
You can see what Qiagen NV (QGEN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.66. Likewise, its price to free cash flow for the trailing twelve months is 18.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.37, a number that is poised to hit 0.50 in the next quarter and is forecasted to reach 2.48 in one year’s time.
Technical Analysis of Qiagen NV (QGEN)
Looking closely at Qiagen NV (NYSE: QGEN), its last 5-days average volume was 1.08 million, which is a drop from its year-to-date volume of 1.3 million. As of the previous 9 days, the stock’s Stochastic %D was 67.01%. Additionally, its Average True Range was 1.20.
During the past 100 days, Qiagen NV’s (QGEN) raw stochastic average was set at 42.85%, which indicates a significant decrease from 74.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.76% in the past 14 days, which was higher than the 31.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $40.04, while its 200-day Moving Average is $43.98. However, in the short run, Qiagen NV’s stock first resistance to watch stands at $42.98. Second resistance stands at $43.33. The third major resistance level sits at $43.62. If the price goes on to break the first support level at $42.34, it is likely to go to the next support level at $42.05. Should the price break the second support level, the third support level stands at $41.70.
Qiagen NV (NYSE: QGEN) Key Stats
There are 222,291K outstanding shares of the company, which has a market capitalization of 9.21 billion. As of now, sales total 1,978 M while income totals 83,590 K. Its latest quarter income was 521,200 K while its last quarter net income were 88,320 K.
